Central versus peripheral mediation of naloxone's perfusion effects in endotoxic rats

Shock

Volumn 14, Issue 4, 2000, Pages 441-446

  Sharma, Avadhesh C ^a   Sam II, Albert D ^a   Alden, Kris J ^a   Moore, Shanda L ^a   Law, William R ^a   Ferguson, James L ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Endothelin; Endotoxemia; Nitric oxide byproducts; Opioid antagonists; Regional blood flow; Regional vascular resistance; Systemic hemodynamics

Indexed keywords

ENDOTHELIN 1; NALOXONE; NARCOTIC ANTAGONIST; NITRIC OXIDE;

ANIMAL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; DRUG EFFECT; ENDOTOXEMIA; HEART OUTPUT; HEART RATE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; ENDOTHELIN-1; ENDOTOXEMIA; HEART RATE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE;

EID: 0034304129     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014040-00004     Document Type: Article

References (27)

1. Boeuf B, Gauvin F, Guerguerian A, Farrell CA, Lacroix J, Jenicek M: Therapy of shock with naloxone: a Meta-analysis. Crit Care Med 26: 1910-1916, 1998.
2. Law WR, Ferguson JL: Respiratory compensation and acidosis in endotoxin shock: effects of naloxone in conscious rats. Circ Shock 21:65-78, 1987.
3. Law WR, Ferguson JL: Naloxone alters organ perfusion during endotoxic shock in conscious rats. Am J Physiol 255:H1106-H1113, 1988.
4. Dziki AJ, Lynch WH, Ramsey CB, Law WR: β-Adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock. Shock 39:29-38, 1993.
5. Law WR, Mourelatos MG, Krahmer R, Dziki AJ, Lynch WH, Ferguson JL: Effects of phentolamine or yohimbine on naloxone's actions during endotoxin shock in rats. Shock 3:217-224, 1997.
6. Romanovsky AA, Shido O, Ungar AL, Blatteis CM: Peripheral naloxone attenuates lipopolysaccharide fever in guinea pigs by an action outside the blood-brain barrier. Am J Physiol 266:R1824-R1831, 1994.
7. Jang W, Schadt JC, Gaddis RR: Peripheral opioidergic mechanisms do not mediate naloxone's pressor effect in the conscious rabbit. Circ Shock 39:121-127, 1993.
8. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29:1469-1477, 1997.
9. Tracey WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 111: 1011-1015, 1995.
10. Law WR, Ritzmann JM, Kapin MA, Ferguson JL: The effects of acute and chronic morphine on regional distribution of cardiac output in brain. Experientia 41:78-80, 1985.
11. Faden AI, Jacobs TP, Feuerstein G, Holaday JW: Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury. Brain Res 213:415-421, 1981.
12. Lechner RB, Gurll NJ, Reynolds DG: Intracoronary naloxone in hemorrhagic shock: dose-dependent stereospecific effects. Am J Physiol 249:H272-H277, 1985.
13. Faden AI, Jacobs TP, Holaday JW: Endorphin-parasympathetic interaction in spinal shock. J Auton Nerv Sys 2:295-304, 1980.
14. Janssen HF, Lutherer L: Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock. Brain Res 194:608-612, 1980.
15. Knowles RG, Merrett M, Salter M, Moncada S: Differential induction of brain, lung, and liver nitric oxide synthase by endotoxin in the rat. Biochem J 270:833-836, 1990.
16. Marczin N, Papapetropoupos A, Catravas JD: Tyrosine kinase inhibitors suppress endotoxin- and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am J Physiol 265:H1014-H1018, 1993.
17. Hoque AM, Marczin N, Catravas JD, Fuchs LC: Anesthesia with sodium pentobarbital enhances lipopolysaccharide-induced cardiovascualr dysfunction in rats. Shock 6:365-370, 1996.
18. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132-1138, 1990.
19. Myhre U, Petterson HT, Risoe C, Giercksky KE: Endothelin-1 and endotoxemia. J Cardiovasc Pharmacol 22:S291-S294, 1993.
20. Nambi P, Pullen M, Slivjak MJ, Ohlstein EH, Stoner B, Smith EF: Endotoxin-mediated plasma endothelin concentration, renal endothelin receptor and renal function. Pharmacology 48:147-156, 1994.
21. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M: Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115:199-204, 1994.
22. Pannen BHJ, Bauer M, Zhang JX, Sobotham JL, Clemens MG: Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 270:H7-H15, 1996.
23. Sharma AC, Gulati A: Role of endothelin in regional vascular system. In Gulati A (ed): Endothelin: role in health and disease. Amsterdam: Harwood Academic Publishers, 1995, pp 215-232.
24. Masaki T: Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235-255, 1995.
25. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F: Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91:1367-1373, 1993.
26. Motew SJ, Mourelatos MG, Miller RN, Ferguson JL, Law WR: Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats. Shock 7:439-446, 1997.
27. Motew SJ, Sam AD, II, Mourelatos MG, Sharma AC, Alden KJ, Ferguson JL, Law WR: Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. J Surg Res 80:326-332, 1998.